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Background: The prevalence of Gastroesophageal Reflux Disease (GERD) in Turkey is reported as 11.6%. Studies of
pulmonary function in asthmatics have demonstrated a correlation between lung resistance and the occurrence of
spontaneous gastroesophageal reflux. Few studies have included measures of lung diffusing capacity for carbon
monoxide. The aim of this study is to assess whether asthma patients had worse lung function and gas diffusion
according to diversity of GERD symptoms they concurrently experienced. The secondary aim of the study is to
determine the frequency and different faces of GERD in our asthma patients compared to healthy controls.
Methods: Sixty consecutive asthma patients evaluatd at the pulmonary specialty outpatient clinic were included in
the study. The control group included 60 healthy volunteers who had normal pulmonary function and routine
laboratory tests. A modified version of a self-reported questionnaire developed by Locke and associates at the Mayo
Clinic was conducted face-to-face with consecutive asthma patients and control subjects. Pulmonary function
measurements were taken using spirometry. DLCO (mL/dk/mmHg) and DLCO/VA (DLCO adjusted according to
alveolar volume) were measured using a single-breath technique. Statistical analyses were performed using the
SPSS 17.0 statistical software.
Results: DLCO and DLCO/VA were significantly lower in asthma patients who had dysphagia symptoms. Frequent
and significant acid regurgitations were seen in 28.33% (n = 17) of patients in the study group and 6.7% (n = 4) of
patients in the control group. Severe, troublesome heartburn symptoms were reported by 28.2% (n = 17) of patients
in the study group and 16.7% (n = 10) of subjects in the control group. Dysphagia was detected in 38.3% (n = 23) of
all asthma cases and in 1.7% (n = 1) of the subjects in the control group.
Conclusions: There were many faces of gastroesophageal reflux disease in our asthmatic patients. Dysphagia was
the only GERD symptom influencing on pulmonary function tests, while gastroesophageal reflux symptoms and
nocturnal awakening attacks were common in this study.
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Gastroesophageal reflux disease (GERD) is rather com-
mon and its prevalence in Turkey is 11.6%. GERD is fre-
quent in adult patients with asthma and the reported
prevalence ranges from 32 to 82% [1-3].
Bor et al. in a study in Turkey reported in patients
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reproduction in any medium, provided the orGERD (heartburn/regurgitation once a week or more)
was 25.4% and 19.4% and that of occasional symptoms
(less than weekly) 21.2% and 27.0%, respectively [4].
Extraesophageal reflux disease is commonly seen at
gastroenterology outpatient clinics as well as ear, nose
and throat, allergy and asthma clinics. The reflux of acid
and pepsin may affect the respiratory tract and cause re-
spiratory problems such as asthma, pneumonia and
interstitial fibrosis. Chronic cough, chronic laryngitis
and asthma are significantly associated with GERD [5].
There is a cause and effect relationship between asthma. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cious cycle. Reflux may precipitate asthma either via a
vagal reflex initiated by gastric fluid in the esophagus or
by micro-aspiration of gastric content into the trachea.
Inversely, asthma may promote reflux due to the
increased gradients pressure between the abdominal cav-
ity and thorax, outgoing the lower esophageal sphincter
pressure barrier [6-8]. Experimental evidence in both
animals and humans has demonstrated reflex stimula-
tion of bronchospasm and cough as a response to
esophageal acidification.
Animal studies also have demonstrated the develop-
ment of laryngeal ulceration and severe bronchospasm
as a result of the direct application of acid into the lar-
ynx or acid inhalation into the airways [9-11]. Some
studies of pulmonary function in asthmatics have
demonstrated a correlation between lung resistance and
occurrence of spontaneous gastroesophageal reflux [12].
In a review by Field at al. there was no objective im-
provement in pulmonary function attributable to GERD
medical therapy. The discomfort associated with GERD
can cause reflux-associated respiratory symptoms even
when the pulmonary function is normal [9].
However, few studies have included measures of the
lung diffusing capacity for carbon monoxide. The only
study on the subject has found that severe GERD is
associated with an impairment of gas exchange [13]. The
aim of this study is to assess whether asthma patients
have worse lung function and gas diffusion according to
the diversity of GERD symptoms they concurrently ex-
perience. The secondary aim of the study is to determine
the frequency of GERD in asthma patients compared to
healthy controls.
Methods
Sixty consecutive asthma patients participated in the
study, and they had been seen at the pulmonary specialty
outpatient clinic at the Taksim Training and Research
Hospital and the Yedikule Chest Disease Hospital between
January 2008 and January 2009. Several inclusion para-
meters were used to determine eligibility for the study. Eli-
gible patients had been diagnosed with asthma according
to the guidelines of the Global Strategy for Asthma Man-
agement (GINA) at least 3 years prior to entry into the
study. The asthma severity of the patients without exacer-
bation was defined in this study as intermittent, mild per-
sistent, moderate persistent, and severe persistent
according to GINA [14]. None of the patients were experi-
encing an asthma exacerbation. All patients were receiving
inhaled steroids, beta agonists or leukotriene antagonists
at an appropriate level for the severity of their disease.
None of the patients had been previously diagnosed
with any other obstructive or restrictive chronic pul-
monary diseases and patients who had pulmonaryabnormalities on chest radiographs were excluded. Add-
itionally, patients with known esophageal disease such as
cancer, achalasia, stricture, active peptic ulcer disease,
Zollinger-Ellison syndrome, and scleroderma as well as
patients who were currently abusing alcohol (more than
three alcoholic drinks a day) were excluded. This was a
the symptom based study, thus an invasive diagnostic
toollike the esophago-gastroduodenoscopy was not used.
Control group
The healthy control group consisted of 60 age-matched
voluntary persons who had a normal pulmonary func-
tion and routine laboratory tests. These subjects denied
having any respiratory symptoms such as dyspnea or
chronic sputum production and did not have a previous
diagnosis of asthma or COPD or any other respiratory
illness. The above-mentioned exclusion causes were also
evaluated in the control group.
Protocol
A modified version of a self-reported questionnaire
developed by Locke and associates at the Mayo Clinic
[15] was conducted face-to-face with consecutive asthma
patients and control subjects. We established the feasibil-
ity, reproducibility, reliability and validity of the Turkish
version for examining four symptoms in detail: heartburn
(which was defined as a burning sensation in the retro-
sternal area), acid regurgitation (which was defined as the
perception of the flow of refluxed gastric content into the
mouth or hypopharynx), dysphagia (which was defined as
a perceived impairment of the passage of food from the
mouth into the stomach) and chronic cough. The first
question for each symptom served as a branch point- sub-
jects who indicated “no” proceeded to the next symptom.
The next two questions for each symptom addressed the
frequency (once in a month, more than once in a month,
once in a week, more than once in a week and daily symp-
toms) and the severity of the symptoms in the last year.
Further questions assessed specific attributes of each
symptom. Other questions assessed the effect of both
heartburn and acid regurgitation on shortness of breath,
cough, wheezing, chest pain, globus and dysphonia. The
remainder of the questions assessed the patient’s demo-
graphic data, smoking history and use of over-the-
counter antacids and prescription anti-reflux medica-
tions. In general, the questionnaires were completed in
< 30 minutes by asthma patients and controls. This
study was approved by our hospital ethics committee and
written informed consent was obtained from all partici-
pants in the study.
Lung function
All FVC (forced vital capacity), FEV1 (forced expiratory
capacity) and PEF (peak expiratory flow) measurements
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spiro program, Spirolab, MIR-Medical International re-
search, Italia). DLCO (mL/dk/mmHg) and DLCO/VA
(DLCO adjusted according to alveolar volume) were
measured using a single-breath technique (model 1070;
Medical Graphics; St. Paul, MN). The hemoglobin level
was known at the time of testing. The DLCO was rou-
tinely adjusted for the hemoglobin if the value was
outside of the normal range. When analyzing the pul-
monary function data, the asthma patients with gastro-
esophageal reflux symptoms were compared to patients
without symptoms. Each of the GER symptoms was se-
parately evaluated.
Statistical analysis
The reliability of the questionnaire was calculated for di-
chotomous choices using kappa statistics (test-retest).
Kappa values were between 0.69–1. The questions were
written using a Likert-type scale and were analyzed with
the Spearman correlation (rs) test (rs values were be-
tween 0.67–0.95). The internal consistency of measures
with dichomotous choices was evaluated by the Kuder-
Richardson Formula 20 (KR–20) and the value obtained
was 0.89. At the same time, the Cronbach α was used to
assess internal consistency for measures with non-
dichomotous choices and was calculated to be 0.85.
The normality of the distribution was assessed using
the Kolmogorov Smirnov test and the Shapiro-Wilk
test by drawing histograms. The data were presented as
mean ± SD, median(min-max), frequency and percentage.
The variables in each group were compared using a
Mann–Whitney U-test. The nominal variable values
were evaluated using the Chi-square test, Yates arranged
Chi-square test and Fisher exact test. Analyses were per-
formed using the SPSS 17.0 statistical software. The stat-
istical significance value was set at p < 0.05.
Results
The male to female ratio of the asthmatic patients was
26/24, while it was 24/26 in the control group. There
was no statistically significant difference between these
two groups with regard to sex (p = 0.14). The mean age
of the study group was 44.85 ± 14.25 years, the mean age
of the control group was 41.48 ± 13.90 years(p > 0.05)Table 1 Demographics of patients with asthma and control su
Variables Asthma Pati
Gender F n(%) 34 (56.7)
M n(%) 26 (43.3)
Age, yr
mean ± SD, median (min.-max.) 44.85 ± 14.25
BMI, kg/m2
mean ± SD, median (min.-max.) 25.93 ± 5.07,(Table 1). According to the GINA classification, 25 out
of 60 patients had intermittent asthma (FEV1 and
PEF ≥ 80%, predicted and variability <20% – step 1), 8
had mild persistent asthma (nocturnal symptoms, vari-
ability 20–30% – step 2), 21 had moderate persistent
asthma (daily symptoms FEV1 and PEF 60–80%. vari-
ability ≥ 30%– step 3) and 6 had severe persistent
asthma (daily symptoms, FEV1 and PEF ≤ 60%, variabi-
lity > 30% – step 4). None of the asthmatic patients was
current smoker, however 10.3% (n = 6) were ex-smokers
and 10.0% (n = 6) of the healthy controls were current
smokers. No subjects in either group drank alcohol.
Patients had not regularly used anti-reflux therapy.
However, 8 had used proton-pomp inhibitors several
times(13.3%). The frequency of any heartburn in the
asthma cases was 53.3% (n = 32) and in the control
group it was 20% (n = 12) (p = 0.001) (Figure 1). The in-
cidence of frequent and significant heartburn (occurring
daily or at least a few times a week) was 16.7% (n = 10)
in the study group and 1.7% (n = 1) in the control group
(p = 0.05) (Figure 2). Severe, troublesome heartburn
symptoms were reported by 28.2% (n = 17) of patients in
the study group and 16.7% (n = 10) of control subjects.
The frequency of regurgitation in asthma patients was
62.7% (n = 37), but only 25% (n = 15) in the control group
(p = 0.001) (Figure 1). Frequent and significant regurgita-
tion was seen in 28.33% (n = 17) of patients in the study
group and 6.7% (n = 4) of control subjects (Figure 2). Se-
vere, troublesome regurgitation (as reported by the
patients) was seen in 27% (n = 10) of the asthmatics with
regurgitation, and 6.7% (n = 1) of subjects in the control
group. Both heartburn and regurgitation were experienced
by 48.3% (n = 29) of asthmatics and 19.3% (n = 11) of con-
trols (p = 0.001) (Figure 2). No significant association was
seen between heartburn, symptoms of regurgitation and a
limitation of daily activities in either the study or the
control group (p = 0.07). Dysphagia was detected in 38.3%
(n = 23) of asthmatics and in 1.7% (n = 1) of controls (p <
0.001) (Figure 1). When patients were questioned in detail,
dysphagia was reported intermittently and more often oc-
curred for solid foods than for liquids. The dysphagia
symptoms experienced by the patients did not progress.
Some patients had a hard time defining the difference
between dysphagia and difficulty swallowing. Frequentbjects
ents (n = 60) Control Subjects (n = 60) p
26 (43.3) 0.14
34 (56.7)
, 44(17.80) 41.48 ± 13.90 (18-72) p > 0.05
25.9(13-42) 24.93 ± 4.40, 24.8(17.7-33.6) p > 0.05
Figure 1 Increased frequency of gastroesophageal reflux
symptoms.
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asthmatics. Dysphonia was seen in 78.3% (n = 47), globus
in 45% (n = 27) of asthmatics and 10% (n = 6) and 11.6%
(n = 7) of controls, respectively (p < 0.01) (Figure 1).
Chest pain was seen in 52.5% (n = 31) of asthma
patients and in only 15% (n = 9) of the control subjects
(p = 0.001). After a detailed history was obtained from
patients with chest pain and the cardiologic workup was
done, 15% (n = 9) of asthma patients had findings of is-
chemia (8.3% (n = 5) and hypertension (6.7% (n = 4).
These findings were detected in 1.7% (n = 1) of controls
(p = 0.01). Seventy percent (n = 42) of asthmatics initially
presented to the hospital with chronic cough and dys-
pnea. Gastroesophageal reflux symptoms were the initial
presentation in only 6.8% (n = 4) of the asthmatics
patients. None of the patients had undiagnosed or previ-
ously known hiatal hernia or esophageal disease. There
was no significant correlation between the presence of
regurgitation symptoms and the clinical severity of
asthma (p = 0.79 and p = 0.73, respectively). Similarly,Figure 2 Significant and frequent gastroesophageal reflux
symptoms (several times a week or everyday) and presence of
heartburn with regurgitation.there was no correlation between heartburn and regurgi-
tation and severe cough (p =0.163 and p = 0.14, respect-
ively). Nevertheless, there was a significant correlation
between the presence of regurgitation and waking up at
night with dyspnea in asthmatic patients (p = 0.005).
When asthma patients with and without heartburn
symptoms were compared, there was no difference in
pulmonary function test parameters such as FEV1,FVC,
FEV1/FVC, PEF and pulmonary diffusion tests para-
meters such as DLCO, DLCO/VA (Table 2). The pres-
ence of heartburn and regurgitation did not affect
pulmonary function. However, when patients with and
without dysphagia symptoms were compared, the pul-
monary diffusion test parameters such as DLCO,
DLCO/VA were significantly lower in patients who had
dysphagia (p = 0.008, p = 0.02, respectively). Similarly,
pulmonary function test parameters such as FEV1, FVC,
PEF were lower in asthma patients with dysphagia (p =
0.044, p = 0.049, p = 0.019) (Table 3).
Discussion
The main findings of this study are the changes of pul-
monary function in patients with dysphagia. In fact, in
this study pulmonary diffusion test parameters such as
DLCO, DLCO/VA were significantly lower in patients
with dysphagia compared to those without dysphagia.
Pulmonary function test parameters such as FEV1, FVC,
PEF, were lower in asthma patients with dysphagia. Pre-
vious studies in the literature have already compared
pulmonary function test results in patients with and
without GERD, while no study has compared the pul-
monary function test results according to diversity of
GERD symptoms.
To the best of our knowledge there are in literature no
studies other than that done by Schachteret al. in which
the pulmonary diffusion capacity was measured in
patients with GERD [13]. That study was performed in a
group composed of obese people with severe GERD
symptoms and a low diffusion capacity was found in
those patients. There is no difference in the prevalence
of asthma and/or airway obstruction in patients with
and without GERD. In our study we did not find any
changes in the diffusion capacity of patients who had
heartburn/regurgitation. In Tan et al. study, GERD has
not been shown to worsen lung function or bronchial
reactivity consistently [16]. Field et al. determined
increased minute ventilation without changing lung
function in non-asthmatic patients exposed to experi-
mental acid perfusion [17]. However, patients with dys-
phagia, had changes in pulmonary diffusion parameters
in this study. The carbon monoxide diffusion test has
been previously found to be either normal or even high
in asthmatic patients [18]. The spectrum of reflux dis-
ease spans from non-erosive reflux disease to esophageal
Table 2 Spirometry and lung diffusion test measurements comparing patients with and without heartburn
Asthma Patients
HB (n = 32) non-HB (n = 28) p
Age mean ± SD 44.69 ± 12.1 45.04 ± 16.6 0.93
BMI mean ± SD 27.05 ± 5.22 26.8 ± 5 0.85
FEV1 L mean ± SD 2.20 ± 0.80 2.08 ± 0.83 0.561
FEV1% of predicted mean ± SD 73.25 ± 21.72 69.32 ± 20.60 0.475
FVC.L mean ± SD 3.01 ± 1.11 2.91 ± 0.89 0.703
FVC% of predicted mean ± SD 82.40 ± 22.11 82.54 ± 16.04 0.977
FEV1 FVC% mean ± SD median (min.-max.) 3.02 ± 10.28 73.9(35-88) 70.53 ± 12.32 71.7(48-94) 0.405
DLCO mean ± SD 26.91 ± 8.19 26.14 ± 8.06 0.717
DLCO% mean ± SD 101.31 ± 20.10 96.71 ± 15.37 0.321
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Barrett’s esophagus and esophageal carcinoma. Pro-
longed exposure of the esophagus to gastric content can
cause dyphagia and this can suggest that undesirable
changes are likely occurring in the lung and esophagus.
In a study of patients with idiopathic pulmonary fibrosis,
83% presented with abnormal distal/proximal esophageal
acid exposure [19].
GERD can cause permanent histopathological changes
in asthma, progression to fibrosis, and decrease in the
response rate to treatment through direct irritation,
hypersensitivity of the airway , and a neural reflex. An
asthma exacerbation results in negative intrathoracic
pressure, which may cause reflux, and medications used
to treat asthma (theophylline, beta-agonists, steroids)
can on turn reduce the lower esophageal sphincter pres-
sure [20-22]. We did not find any study that showed the
relationship with pulmonary fibrosis and dysphagia in
asthma patients. However, Savarino et al. study exploredTable 3 Spirometry and diffusion capacity of the lung for
carbon monoxide in patients with and without dysphagia
PFT Results in Asthma Group





Age, yr 45.3 ± 14.7 44.57 ± 14.16 0.85
BMI 26.44 ± 6.28 27.24 ± 4.27 0.56
FEV1.L 1.89 ± 0.68 2.30 ± 0.86 0.044
FEV1% of predicted 68.69 ± 23.17 73.10 ± 19.88 0.454
FVC.L 2.66 ± 0.82 3.15 ± 1.07 0.049
FVC% of predicted 81.69 ± 20.74 83.08 ± 18.71 0.766
FEV1.FVC.% 70.63 ± 13.48 72.55 ± 9.85 0.564
DLCO 23.38 ± 6.19 28.54 ± 8.54 0.009
DLCO% 92.00 ± 13.59 103.62 ± 19.17 0.008
DLCO/VA 4.96 ± 0.81 6.30 ± 4.78 0.0103
DLCO/VA 98.66 ± 16.19 114.67 ± 19.77 0.002the association of GERD and pulmonary fibrosis in
patients with scleroderma with and without pulmonary
fibrosis. Their findings suggested that patients with cuta-
neous systemic sclerosis and pulmonary fibrosis have
more extensive esophageal involvement, leading to more
severe GERD. Low LES (lower esophageal sphincter)
pressure and smooth muscle dysfunction (i.e., uncoor-
dinated pressure waves and reduced or absent peristal-
sis) predisposed to GERD in these patients [23,24]. Their
experiments can be model to explain the coincidence of
dysphagia and pulmonary fibrosis [23-25]. The result of
Masato et al. study supported that lung inflation modu-
lated the swallowing reflex [26].The observed impaired
breathing and swallowing patterns in the patients with
COPD suggests a possible explanation for the develop-
ment of dysphagia [27-29]. Our study was limited to
prove the progression to pulmonary fibrosis or lung in-
flation with radiologic tools in asthmatic patients with
dysphagia. Recurrent airway inflammation and aberrant
remodeling is thought to be the basis of the fibrotic re-
sponse seen in patients with asthma. The numbers of
fibrocytes were significantly increased in the lamina pro-
pria and in the peripheral blood of patients with severe
asthma [29-31]. Both the asthma itself and accompani-
ment of GERD may predispose to fibrosis. In this study
the incidence of dysphagia was similar to that reported
by Vakil et al., that is 37% in patients with erosive
esophagitis [32]. In another study on asthma patients,
we detected dysphagia in 26.7% of patients with eso-
phagitis [33]. When patients were questioned in detail,
dysphagia was noted to be intermittent and non-
progressive. Non-troublesome and non-progressive dys-
phagia is common in GERD. Non-progressive dysphagia
can resolve in most patients. In this study, the incidence
of frequent and significant dysphagia was 16.7%. How-
ever, none of the patients had progressive dysphagia. In
patients with troublesome and frequent dysphagia the
extent to which the dysphagia progresses should always
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tom that warrants further examination for peptic stric-
ture and upper gastrointestinal malignancy [34].
According to the Montreal definition and classifica-
tion, heartburn and/or regurgitation are typical gastroe-
sophageal reflux symptoms [12]. In this study the
incidence of heartburn and acid regurgitation symptoms
in asthma patients were consistent with the literature
[1-3]. Frequent acid regurgitation was seen in 28.3% of
asthma patients. The incidence of acid regurgitation
detected in asthma patients in this study was similar to
the findings of Boret al. (25.4% of asthmatic subjects had
heartburn/regurgitation once a week or more) [4]. When
questioning patients, it is important to make sure that
patients understand the meaning of each symptom [5].
While severe heartburn and regurgitation were present
in 28.2% and 27% respectively of the studied patients,
these percentages reflect the personal perception of the
severity of symptoms and may be subject to personal
and individual differences. Moreover, none of our
patients had reflux symptoms that limited their daily ac-
tivities. Heartburn/regurgitation symptoms coexisted in
48.3% of asthma patients. In the study by Klauseret al.
that examined a patients’ population referred for pH
monitoring, a sensitivity of 78% and a specificity of 60%
for heartburn were reported [35]. The study by
Moayyedi P. et al. showed that patients with “dominant
heartburn” have a 50% chance of having GERD, as diag-
nosed by 24-h esophageal pH studies [36]. Furthermore,
nonacid esophageal reflux (pH of > 4) has also been
recognized [37,38]. A varying prevalence of non-cardiac
chest pain has been reported in studies from a variety of
countries. A number of studies have reported a popula-
tion prevalence of chest pain of up to 25% [39]. A study
in China was similar to our study with a population
prevalence of chest pain of 20.6%. The authors found
that GERD was present in 51% of subjects with non-
cardiac chest pain [40]. GERD can cause episodes of
chest pain that resemble ischemic cardiac pain without
accompanying heartburn or regurgitation according to
the Montreal definition and classification. Esophageal
motor disorders can also cause chest pain by a mechan-
ism separate from gastroesophageal reflux [5]. Further-
more, non-respiratory symptoms such as chest pain are
common symptoms of an asthma attack prodrome and
become more frequent after the onset of the attack [41].
Future studies that investigate chest pain in the setting
of GERD and asthma should take into account these
contradictions. In the present study there was no signifi-
cant correlation between the presence of gastroesopha-
geal symptoms and the clinical severity of asthma. On
the contrary, in some studies the severity of asthma has
been associated with reflux symptoms. In fact, reflux
symptoms were present in 30% of patients with mildasthma, 76% of those with moderate asthma and 70% of
those with severe asthma [36]. However, other studies
do not support these findings. Patients with well-
controlled asthma with and without pH probe-
documented acid reflux were compared in a study by Di
Mango et al. and their results did not support the con-
clusion that asymptomatic reflux is associated with
decreased lung function, worsen asthma control,
increased airway hyperresponsiveness or increased
asthma symptoms [42]. Many more studies are needed
to investigate the association between reflux symptoms
and the severity of asthma. However, the presence of
acid regurgitation was significantly correlated with noc-
turnal awakening with dyspnea in this study. Compared
to non-asthmatics, asthmatic patients have significantly
more frequent and severe day and night GERD symp-
toms and significantly more pulmonary symptoms (noc-
turnal suffocation, cough or wheezing) often associated
with GERD [43]. In a study done in Brazil, awakening
from sleep was the most frequent symptom found at the
onset of GERD, and preceded 38% of nocturnal GERD.
Sleep stage 2 was also prevalent and preceded 36% of
GER events [44].
Conclusions
In conclusion, dysphagia was the only influential GERD
symptom on pulmonary function test while gastroeso-
phageal reflux symptoms and nocturnal awakening
attacks were common in this study. Dysphagia should be
an alarm sign for the pulmonologist in the same manner
that it is for the gastroenterologist. A pulmonary carbon
monoxide diffusion test should be used in the follow up
of patients who have coexisting asthma and GERD.
However, more studies that investigate this topic are
needed.
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